Federal Circuit Refuses Rehearing Of Homocysteine Assay Patent Case

By Marius Meland

Law360, New York (August 06, 2004, 12:00 AM ET) -- The U.S. Court of Appeals for the Federal Circuit has denied LabCorp's petition for a rehearing of a lawsuit brought by Competitive Technologies on behalf of two university clients over a homocysteine assay patent.

"CTT and its clients have successfully prevailed in multiple venues in this important case. We applaud the Court of Appeals for the Federal Circuit’s decision to reaffirm the lower court's decision and will work with LabCorp for a final licensing agreement,” John B. Nano, CTT's President and CEO, said in a statement....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

Already a subscriber?

  2. Forgot your password?
  4. Sign In

Get instant access to the one-stop news source for business lawyers

You must correct or enter the following before you can submit this form:

Required

Register